Biotech · Private company
Basilea Pharmaceutica
Track this companyFree. Adds Basilea Pharmaceutica to your Dealase workspace and tells you when its record changes.
Clinical trials234 recruiting or active
Pipeline programs40From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline40
- CaspofunginPhase 3 · CandidemiaClinicalTrials.gov · fetched Nov 12, 2026
- ceftobiprole medocarilPhase 3 · Acute Bacterial Skin and Skin Structure InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- Ceftobiprole medocarilPhase 3 · Staphylococcus Aureus BacteremiaClinicalTrials.gov · fetched Nov 12, 2026
- Ceftobiprole medocarilPhase 3 · Neonatal SepsisClinicalTrials.gov · fetched Nov 12, 2026
- DaptomycinPhase 3 · Staphylococcus Aureus BacteremiaClinicalTrials.gov · fetched Nov 12, 2026
- FluconazolePhase 3 · CandidemiaClinicalTrials.gov · fetched Nov 12, 2026
- FosmanogepixPhase 3 · CandidemiaClinicalTrials.gov · fetched Nov 12, 2026
- Fosmanogepix IV infusionPhase 3 · Invasive Mold InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- Fosmanogepix oral tabletPhase 3 · Invasive Mold InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- vancomycin+aztreonamPhase 3 · Acute Bacterial Skin and Skin Structure InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- APX001Phase 2 · CandidemiaClinicalTrials.gov · fetched Nov 12, 2026
- derazantinibPhase 2 · Intrahepatic CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- DerazantinibPhase 2 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Derazantinib 200 mg once daily + atezolizumab 1200 mgPhase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Derazantinib 200 mg twice daily + atezolizumab 1200 mgPhase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Derazantinib 300 mg once daily monotherapyPhase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Derazantinib 300 mg once daily monotherapy (QD)Phase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Derazantinib 300 mg once daily+ atezolizumab 1200 mgPhase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Derazantinib at recommended phase 2 dose (RP2D)Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Derazantinib high dose rangePhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Derazantinib low dose rangePhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Derazantinib middle dose rangePhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Derazantinib-paclitaxel-ramucirumab combinationPhase 2 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- fosmanogepixPhase 2 · Invasive Fungal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- amoxicillin-clavulanatePhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- APX001Phase 1 · Invasive Fungal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- APX001APhase 1 · Invasive Fungal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- ceftibutenPhase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
- CeftibutenPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Ceftibuten-ledaborbactam etzadroxilPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Ceftobiprole medocarilPhase 1 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- EsomeprazolePhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- FosmanogepixPhase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- Intravenous fosmanogepixPhase 1 · End Stage Renal Disease on DialysisClinicalTrials.gov · fetched Nov 12, 2026
- ledaborbactam etzadroxilPhase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
- Ledaborbactam etzadroxilPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Microtubule-Targeted Agent BAL101553Phase 1 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Radiation TherapyPhase 1 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- VNRX-7145Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- VNRX-7145Phase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials23
- A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on DialysisPHASE1 · RECRUITING · started Oct 27, 2026ClinicalTrials.gov NCT07916181 · fetched Nov 12, 2026
- A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.PHASE3 · RECRUITING · started Aug 26, 2025ClinicalTrials.gov NCT06925321 · fetched Nov 12, 2026
- Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose CombinationPHASE1 · RECRUITING · started Jan 7, 2025ClinicalTrials.gov NCT06733675 · fetched Nov 12, 2026
- A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.PHASE3 · RECRUITING · started Dec 11, 2024ClinicalTrials.gov NCT05421858 · fetched Nov 12, 2026
- Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Adults (18-55 Years)PHASE1 · COMPLETED · started Nov 4, 2024ClinicalTrials.gov NCT06665555 · fetched Nov 12, 2026
- Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of AgePHASE3 · COMPLETED · started Aug 6, 2023ClinicalTrials.gov NCT05856227 · fetched Nov 12, 2026
- A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function.PHASE1 · COMPLETED · started Oct 31, 2022ClinicalTrials.gov NCT05582187 · fetched Nov 12, 2026
- Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal FunctionPHASE1 · COMPLETED · started Oct 12, 2022ClinicalTrials.gov NCT05488678 · fetched Nov 12, 2026
- Food Effect on Ceftibuten/VNRX-7145 in Healthy ParticipantsPHASE1 · COMPLETED · started Sep 13, 2022ClinicalTrials.gov NCT05527834 · fetched Nov 12, 2026
- A Bioequivalence Study of APX001 High-load and Low-load TabletsPHASE1 · COMPLETED · started Mar 2, 2021ClinicalTrials.gov NCT05491733 · fetched Nov 12, 2026
- Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric AdenocarcinomaPHASE1_PHASE2 · TERMINATED · started Oct 6, 2020ClinicalTrials.gov NCT04604132 · fetched Nov 12, 2026
- VNRX-7145 SAD/MAD Safety and PK in Healthy Adult VolunteersPHASE1 · COMPLETED · started Jan 20, 2020ClinicalTrials.gov NCT04243863 · fetched Nov 12, 2026
- Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare MoldsPHASE2 · TERMINATED · started Jan 4, 2020ClinicalTrials.gov NCT04240886 · fetched Nov 12, 2026
- Derazantinib and Atezolizumab in Patients With Urothelial CancerPHASE1_PHASE2 · COMPLETED · started Aug 2, 2019ClinicalTrials.gov NCT04045613 · fetched Nov 12, 2026
- An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With CandidemiaPHASE2 · COMPLETED · started Oct 3, 2018ClinicalTrials.gov NCT03604705 · fetched Nov 12, 2026
- Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus BacteremiaPHASE3 · COMPLETED · started Aug 26, 2018ClinicalTrials.gov NCT03138733 · fetched Nov 12, 2026
- Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure InfectionsPHASE3 · COMPLETED · started Feb 19, 2018ClinicalTrials.gov NCT03137173 · fetched Nov 12, 2026
- Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaPHASE1 · TERMINATED · started Dec 15, 2017ClinicalTrials.gov NCT03250299 · fetched Nov 12, 2026
- Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic CholangiocarcinomaPHASE2 · COMPLETED · started Sep 28, 2017ClinicalTrials.gov NCT03230318 · fetched Nov 12, 2026
- Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic AntibioticsPHASE1 · TERMINATED · started Nov 22, 2016ClinicalTrials.gov NCT02527681 · fetched Nov 12, 2026
- Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic AlterationsPHASE1_PHASE2 · COMPLETED · started Dec 10, 2012ClinicalTrials.gov NCT01752920 · fetched Nov 12, 2026
- Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand EczemaPHASE3 · COMPLETED · started Jan 8, 2009ClinicalTrials.gov NCT00817063 · fetched Nov 12, 2026
- Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsPHASE3 · COMPLETED · started Mar 8, 2007ClinicalTrials.gov NCT00413218 · fetched Nov 12, 2026